Cargando…
Differential Cell Line Susceptibility to the SARS-CoV-2 Omicron BA.1.1 Variant of Concern
The unique mutations of the SARS-CoV-2 Omicron variant are associated with increased transmissibility, immune escape, increased binding affinity to ACE-2, and increased viral load. Omicron exhibited a shift in tropism infecting the upper respiratory tract compared to other variants of concern which...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696227/ https://www.ncbi.nlm.nih.gov/pubmed/36423057 http://dx.doi.org/10.3390/vaccines10111962 |
_version_ | 1784838256394764288 |
---|---|
author | Dighe, Hitesh Sarkale, Prasad Patil, Deepak Y. Mohandas, Sreelekshmy Shete, Anita M. Sahay, Rima R. Lakra, Rajen Patil, Savita Majumdar, Triparna Gawande, Pranita Yemul, Jyoti Vedpathak, Pratiksha Yadav, Pragya D. |
author_facet | Dighe, Hitesh Sarkale, Prasad Patil, Deepak Y. Mohandas, Sreelekshmy Shete, Anita M. Sahay, Rima R. Lakra, Rajen Patil, Savita Majumdar, Triparna Gawande, Pranita Yemul, Jyoti Vedpathak, Pratiksha Yadav, Pragya D. |
author_sort | Dighe, Hitesh |
collection | PubMed |
description | The unique mutations of the SARS-CoV-2 Omicron variant are associated with increased transmissibility, immune escape, increased binding affinity to ACE-2, and increased viral load. Omicron exhibited a shift in tropism infecting the upper respiratory tract compared to other variants of concern which have tropism for the lower respiratory tract. The tropism of omicron variants in cell lines of different hosts and tissue origins still remains unclear. Considering this, we assessed the susceptibility of different cell lines to the SARS-CoV-2 omicron BA.1.1 variant and permissiveness among different cell lines for omicron replication. Susceptibility and permissiveness of a total of eleven cell lines, including six animal cell lines and five human cell lines for omicron BA.1.1 infection, were evaluated by infecting individual cell lines with omicron BA.1.1 isolate at a 0.1 multiplicity of infection. Virus replication was assessed by observation of cytopathic effects followed by viral load determination by real-time PCR assay and virus infectivity determination by TCID50 assay. The characteristic cytopathic effect, increased viral load, and productive omicron replication was detected in Vero CCL-81, Vero E6, Vero/hSLAM, MA-104, and Calu-3 cells. Although LLC MK-2 cells showed an increased TCID50 titer at the second infection, the viral load did not show much difference in both infections. Caco-2 cells did not show evident CPE, but they supported omicron replication at a low level. A549, RD, MRC-5, and BHK-21 cells supported omicron BA.1.1 replication without the CPE. This is the first study on the comparison of susceptibility of different cell lines to Omicron variant BA.1.1, which might be useful for future studies on emerging SARS-CoV-2 variants. |
format | Online Article Text |
id | pubmed-9696227 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96962272022-11-26 Differential Cell Line Susceptibility to the SARS-CoV-2 Omicron BA.1.1 Variant of Concern Dighe, Hitesh Sarkale, Prasad Patil, Deepak Y. Mohandas, Sreelekshmy Shete, Anita M. Sahay, Rima R. Lakra, Rajen Patil, Savita Majumdar, Triparna Gawande, Pranita Yemul, Jyoti Vedpathak, Pratiksha Yadav, Pragya D. Vaccines (Basel) Article The unique mutations of the SARS-CoV-2 Omicron variant are associated with increased transmissibility, immune escape, increased binding affinity to ACE-2, and increased viral load. Omicron exhibited a shift in tropism infecting the upper respiratory tract compared to other variants of concern which have tropism for the lower respiratory tract. The tropism of omicron variants in cell lines of different hosts and tissue origins still remains unclear. Considering this, we assessed the susceptibility of different cell lines to the SARS-CoV-2 omicron BA.1.1 variant and permissiveness among different cell lines for omicron replication. Susceptibility and permissiveness of a total of eleven cell lines, including six animal cell lines and five human cell lines for omicron BA.1.1 infection, were evaluated by infecting individual cell lines with omicron BA.1.1 isolate at a 0.1 multiplicity of infection. Virus replication was assessed by observation of cytopathic effects followed by viral load determination by real-time PCR assay and virus infectivity determination by TCID50 assay. The characteristic cytopathic effect, increased viral load, and productive omicron replication was detected in Vero CCL-81, Vero E6, Vero/hSLAM, MA-104, and Calu-3 cells. Although LLC MK-2 cells showed an increased TCID50 titer at the second infection, the viral load did not show much difference in both infections. Caco-2 cells did not show evident CPE, but they supported omicron replication at a low level. A549, RD, MRC-5, and BHK-21 cells supported omicron BA.1.1 replication without the CPE. This is the first study on the comparison of susceptibility of different cell lines to Omicron variant BA.1.1, which might be useful for future studies on emerging SARS-CoV-2 variants. MDPI 2022-11-18 /pmc/articles/PMC9696227/ /pubmed/36423057 http://dx.doi.org/10.3390/vaccines10111962 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Dighe, Hitesh Sarkale, Prasad Patil, Deepak Y. Mohandas, Sreelekshmy Shete, Anita M. Sahay, Rima R. Lakra, Rajen Patil, Savita Majumdar, Triparna Gawande, Pranita Yemul, Jyoti Vedpathak, Pratiksha Yadav, Pragya D. Differential Cell Line Susceptibility to the SARS-CoV-2 Omicron BA.1.1 Variant of Concern |
title | Differential Cell Line Susceptibility to the SARS-CoV-2 Omicron BA.1.1 Variant of Concern |
title_full | Differential Cell Line Susceptibility to the SARS-CoV-2 Omicron BA.1.1 Variant of Concern |
title_fullStr | Differential Cell Line Susceptibility to the SARS-CoV-2 Omicron BA.1.1 Variant of Concern |
title_full_unstemmed | Differential Cell Line Susceptibility to the SARS-CoV-2 Omicron BA.1.1 Variant of Concern |
title_short | Differential Cell Line Susceptibility to the SARS-CoV-2 Omicron BA.1.1 Variant of Concern |
title_sort | differential cell line susceptibility to the sars-cov-2 omicron ba.1.1 variant of concern |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696227/ https://www.ncbi.nlm.nih.gov/pubmed/36423057 http://dx.doi.org/10.3390/vaccines10111962 |
work_keys_str_mv | AT dighehitesh differentialcelllinesusceptibilitytothesarscov2omicronba11variantofconcern AT sarkaleprasad differentialcelllinesusceptibilitytothesarscov2omicronba11variantofconcern AT patildeepaky differentialcelllinesusceptibilitytothesarscov2omicronba11variantofconcern AT mohandassreelekshmy differentialcelllinesusceptibilitytothesarscov2omicronba11variantofconcern AT sheteanitam differentialcelllinesusceptibilitytothesarscov2omicronba11variantofconcern AT sahayrimar differentialcelllinesusceptibilitytothesarscov2omicronba11variantofconcern AT lakrarajen differentialcelllinesusceptibilitytothesarscov2omicronba11variantofconcern AT patilsavita differentialcelllinesusceptibilitytothesarscov2omicronba11variantofconcern AT majumdartriparna differentialcelllinesusceptibilitytothesarscov2omicronba11variantofconcern AT gawandepranita differentialcelllinesusceptibilitytothesarscov2omicronba11variantofconcern AT yemuljyoti differentialcelllinesusceptibilitytothesarscov2omicronba11variantofconcern AT vedpathakpratiksha differentialcelllinesusceptibilitytothesarscov2omicronba11variantofconcern AT yadavpragyad differentialcelllinesusceptibilitytothesarscov2omicronba11variantofconcern |